Gene · 407019
Papers3,646
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
161 to 180 of 3,646
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| In silico analysis of prognostic and diagnostic significance of target genes from prostate cancer cell lines derived exomicroRNAs. | Cancer Cell Int | 2023 | 37978493 | PubTator, text mining | PubMed |
| Factors affecting the GABAergic synapse function in Alzheimer's disease: Focus on microRNAs. | Ageing Res Rev | 2023 | 37967653 | PubTator, text mining | PubMed |
| Association of noncoding RNAs with Kawasaki disease: A meta-analysis based on the current evidences. | Medicine (Baltimore) | 2023 | 37960719 | PubTator, text mining | PubMed |
| Atherosclerosis and Its Related Laboratory Biomarkers. | Int J Mol Sci | 2023 | 37958528 | PubTator, text mining | PubMed |
| MiRNAs and Their Role in Venous Thromboembolic Complications. | Diagnostics (Basel) | 2023 | 37958279 | PubTator, text mining | PubMed |
Exosomal miR-146a-5p derived from human umbilical cord mesenchymal stem cells can alleviate antiphospholipid antibody-induced trophoblast injury and placental dysfunction by regulating the TRAF6/NF-κB axis. | J Nanobiotechnology | 2023 | 37957714 | PubTator, text mining | PubMed |
| Advances in Mesenchymal stem cells regulating macrophage polarization and treatment of sepsis-induced liver injury. | Front Immunol | 2023 | 37954578 | PubTator, text mining | PubMed |
| CIZ1 aggravates gastric cancer progression via mediating FBXL19-AS1 and miR-339-3p. | Heliyon | 2023 | 37954363 | PubTator, text mining | PubMed |
| The burden of rare variants in DPYS gene is a novel predictor of the risk of developing severe fluoropyrimidine-related toxicity. | Hum Genomics | 2023 | 37946254 | PubTator, text mining | PubMed |
| Therapeutic Effects of Mesenchymal/Stromal Stem Cells and Their Derived Extracellular Vesicles in Rheumatoid Arthritis. | Stem Cells Transl Med | 2023 | 37934808 | PubTator, text mining | PubMed |
| Mesenchymal stem cells under epigenetic control - the role of epigenetic machinery in fate decision and functional properties. | Cell Death Dis | 2023 | 37932257 | PubTator, text mining | PubMed |
| Identification of novel circulating miRNAs biomarkers for healthy obese and lean children. | BMC Endocr Disord | 2023 | 37904219 | PubTator, text mining | PubMed |
| Differential expression of plasma‑derived exosomal miRNAs in polycystic ovary syndrome as a circulating biomarker. | Biomed Rep | 2023 | 37901874 | PubTator, text mining | PubMed |
| Early to sustained impacts of lethal radiation on circulating miRNAs in a minipig model. | Sci Rep | 2023 | 37898651 | PubTator, text mining | PubMed |
| Analysis of miRNAs in Osteogenesis imperfecta Caused by Mutations in COL1A1 and COL1A2: Insights into Molecular Mechanisms and Potential Therapeutic Targets. | Pharmaceuticals (Basel) | 2023 | 37895885 | PubTator, text mining | PubMed |
| Novel Biomarkers and Their Role in the Diagnosis and Prognosis of Acute Coronary Syndrome. | Life (Basel) | 2023 | 37895374 | PubTator, text mining | PubMed |
| Molecular Insight into Prostate Cancer: Preventive Role of Selective Bioactive Molecules. | Life (Basel) | 2023 | 37895357 | PubTator, text mining | PubMed |
| Circulating microRNA Panels for Detection of Liver Cancers and Liver-Metastasizing Primary Cancers. | Int J Mol Sci | 2023 | 37895131 | PubTator, text mining | PubMed |
| PDZ and LIM Domain-Encoding Genes: Their Role in Cancer Development. | Cancers (Basel) | 2023 | 37894409 | PubTator, text mining | PubMed |
| Peripheral blood mononuclear cells expression of miR-200c, miR-125b, miR-27b, miR-203, and miR-155 in patients with significant or insignificant coronary artery stenosis. | Sci Rep | 2023 | 37891322 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/407019/papers?page=9